Constraints on the Effectiveness of Structural Adjustment Packages in the Production and Availability of Pharmaceutical Products in Kenya

  • Pius Owino

Abstract

According to the orthodox adjustment programmes, depreciation of the real exchange rate (RXR), ceteris paribus, induces price incentives in favour of the production and export of Tradable (T) goods relative to non-tradable (N) goods. Trade liberalisation is supposed to reduce protection and improve economic efficiency, while reduction in government spending offsets the inflationary impact of devaluation. In practice, however, many constraints offset these intended objectives. This chapter aims to highlight these constraints by examining the impact of these three policy instruments on the production and availability of pharmaceutical products (PPs) in Kenya. To start with, we examine whether price incentives make the production and export of T goods including PPs more profitable relative to N goods.

Keywords

Sugar Starch Maize Europe Transportation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abel-Smith, B. and Rawal, P. (1992) ‘Can Poor Afford ‘Free’ Health Services? A Case Study of Tanzania’, Health Policy and Planning, Vol. 7, No. 4, pp. 329–41 (Oxford University Press).CrossRefGoogle Scholar
  2. Alexander, C.P. (1984) ‘Prescriptions for Cheap Drugs’, Time, New York, September, 14.Google Scholar
  3. Ballance, R., Poga’ny, J. and Forstner, H. (1992) The World’s Pharmaceutical Industries: An International Perspective on Innovation, Competition and Policy (Aldershot: Edward Elgar).Google Scholar
  4. Controller and Auditor General’s Report (CAG), Kenya: Appropriation Accounts (various issues).Google Scholar
  5. Coughlin, P. and Ikiara G.K. (eds) (1991) Kenya’s Industrialisation Dilemma (Nairobi: Heinemann).Google Scholar
  6. De Groot, A.W. (1991) ‘Adjustment Policies and the Real Exchange Rate in Kenya since 1975’, World Development, vol. 19, no. 10.CrossRefGoogle Scholar
  7. Foster, S.D. (1993) ‘Economic Aspects of the Production and Use of Pharmaceuticals: Evidence and Gaps in Research’, in Mills, A. and Lee, K. (eds) Health Economics Research in Developing Countries (Oxford: Oxford University Press).Google Scholar
  8. Goldstein, M. and Khan, M. (1978) ‘The Supply and Demand for Exports: A Simultaneous Approach’, Review of Economics and Statistics.Google Scholar
  9. Havemann, K. et al., (1990) ‘A Study of the Utilisation of Essential Drugs in Three Districts of Kenya’, Vol. I and II, Essential Drugs Programme (Kenya: Ministry of Helath), Nairobi, Kenya, October.Google Scholar
  10. International Monetary Fund (IMF) International Financial Statistics Yearbook 1992–93 (Washington DC: IMF).Google Scholar
  11. Julin, E. and Levin, J. (1992) ‘Kenya: Macroeconomic Performance 1990 and Some Issues Related to Structural Adjustment Programmes’, Department of Economics, University of Gothenburg, Report No. 30/92.Google Scholar
  12. Kanji, N. et al. (1992) Drugs Policy in Developing Countries (London: Zed Books).Google Scholar
  13. Kenya, Government of, Statistical Abstracts, Government Printer, Nairobi (various issues).Google Scholar
  14. Kenya, Government of, Annual Trade Reports, Government Printer, Nairobi (various issues).Google Scholar
  15. Kenya, Ministry of Health, ‘SIDA Supported Health Programmes in Kenya: Workplan and Budgets, Nairobi (various issues).Google Scholar
  16. Killick, T. (1990) ‘Exchange Rates and Structural Adaptation’, Overseas Development Institute, Working Paper No. 33, London.Google Scholar
  17. Laird, S. and Yeats, A. (1988) ‘ Trends in Nontariff Barriers of Developed Countries 1966–1986’, World Bank Working Paper, WPS 137, December.Google Scholar
  18. Milner, C. (1990) ‘Policy Appraisal and the Structure of Protection in a Low–Income Developing Country: Problems of Measurement and Evaluation in Burundi’, Journal of Development Studies, 27: 1, pp. 22–42.CrossRefGoogle Scholar
  19. Ministry of Health (MOH) and SIDA (various issues) SIDA Supported Health Programmes in Kenya: Progress Report (January–June) , Nairobi: Ministry of Health.Google Scholar
  20. MOH/SIDA/DANIDA/WHO (1984) ‘Management of Drug Supplies to Rural Health Facilities in Kenya’, EDP Evaluation Report, EDP, Nairobi.Google Scholar
  21. Mosley, P. (1991) ‘Kenya’ in Mosley et al. (eds) Aid and Power (London: Rontledge).Google Scholar
  22. Muzulu, J. (1993) ‘Real Exchagne Rate Depreciation and Structural Adjustment: The Case of the Manufacturing Sector in Zimbabwe (1980–91) ’, D. Phil Dissertation, IDS, University of Sussex.Google Scholar
  23. New Africa (1990) IC Publications Ltd; No. 278, November.Google Scholar
  24. Owino, P.S.W. (1993) ‘The Impact of Structural Adjustment on the Production, and Availabiity of Pharmaceutical Products in Kenya’, DPhil Dissertation, IDS, University of Sussex.Google Scholar
  25. Owino, P.S.W. (1985) ‘The Pharmaceutical Industry in Kenya’, unpublished MA Research Paper, University of Nairobi.Google Scholar
  26. Riedel, J. (1988) ‘The Demand for LDC Exports of Manufactures: Estimates from Hong Kong’, Economic Journal, vol. 98, no. 389, March.CrossRefGoogle Scholar
  27. Segall, M. et al. (1989) Expenditure and Financing of the Health Sector in Kenya, Report of a Study Commissioned by the World Bank and Performed in Association with Ministry of Health (Kenya).Google Scholar
  28. Velasco, A. (ed.). (1988) Trade, Development and the World Economy: Selected Essays of Carlos Diaz–Alejandro (Oxford: Basil Blackwell).Google Scholar
  29. World Bank (1990e) ‘Kenya Stabilisation and Adjustment: Towards Accelerated Growth’, Report No. 9047—KE, Washington DC.Google Scholar

Copyright information

© Charles Harvey 1996

Authors and Affiliations

  • Pius Owino

There are no affiliations available

Personalised recommendations